cfDNA fragment sizes in regions of ASCL1 binding were larger, presumably reflecting the decreased contribution of the tumor-derived cfDNA at these regions23 (Supplementary Fig. 10a, c). The gene discussed is ASCL1; the disease is neoplasm.